Response to Varying the Rate of Administration of a Fluid Challenge
NCT ID: NCT03300323
Last Updated: 2017-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2017-10-31
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to investigate the optimal rate to give a fluid challenge over. Patients will be randomised to receive a fluid challenge over either 5 or 20 minutes. Both of these rates are within the currently accepted range. All patients will receive a dose of 4ml/kg of intravenous fluid. Previous work has shown this to be the optimal dose to reliably stress the system.
Measurement of the mean pressure in the cardiovascular system (mean systemic filling pressure or Pmsf) during the administration of a fluid challenge will be used to assess which rate of administration effectively challenges the cardiovascular system. Pmsf is measured using a pneumatic tourniquet inflated for sixty seconds, above an arterial line. The invasive arterial pressure is observed to then determine Pmsf. Cardiac output will also be monitored during and after administration of the fluid challenge. Since the microcirculation may remain impaired despite stabilisation of the macrocirculation, we will also observe this at baseline, on completion of the fluid challenge, and at 5 minute intervals for 15 minutes. This is observed using a handheld camera placed under the tongue.
The hypothesis is that administration of a fluid challenge at a faster rate, over 5 minutes as opposed to 20 minutes, will be a more effective test of the cardiovascular response. An effective fluid challenge is defined as one that causes a significant rise in mean systemic filling pressure. As such, a higher proportion of responders will be seen in response to the faster rate of fluid challenge. A responder is defined by an increase in cardiac output or stroke volume of more than 10% from baseline in response to a fluid challenge.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IV Fluid challenge administration _5
4ml/kg intravenous fluid challenge administered over 5 minutes
IV fluid challenge administration
Administration of an intravenous fluid challenge to assess for fluid responsiveness
IV Fluid challenge administration 20
4ml/kg intravenous fluid challenge administered over 20 minutes
IV fluid challenge administration
Administration of an intravenous fluid challenge to assess for fluid responsiveness
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IV fluid challenge administration
Administration of an intravenous fluid challenge to assess for fluid responsiveness
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients, aged \>18 years, who have given informed consent to participate in the study.
Exclusion Criteria
* Patients requiring aggressive fluid resuscitation due to life-threatening cardiovascular instability, such would not allow for period of observation for stability as defined in protocol.
* Pregnancy
* Possible contraindications to the use of the cardiac output monitoring device, or pathology known to affect accuracy of readings, including
* Extensive peripheral arterial occlusive disease in upper limbs
* Postoperative valvular insufficiency
* New onset arrhythmia
* Cardiac assist device
* Right ventricular failure, (formal pre-operative diagnosis)
* Severe left ventricular failure or diastolic dysfunction
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St George's Healthcare NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurizio Cecconi
Role: STUDY_CHAIR
St George's University Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Maurizio Cecconi
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17.0092
Identifier Type: -
Identifier Source: org_study_id